The Siemens sector Healthcare has developed the new consulting model “Act on Stroke”, tailored specifically to clinical workflows in the treatment of stroke.
Following models for industry processes, an expert team from Siemens evaluates the maturity level of clinical processes in a hospital. Based on a data pool that integrates the knowledge of leading hospitals worldwide, Siemens consultants support the optimization of clinical workflows, aiming at measurably higher quality of care for stroke patients.
At Medica 2010, Siemens presents the new approach and first consultation projects with “Act on Stroke”.
“Time is Brain” is a key principle in neurology and expresses the importance of time with respect to stroke care: the quicker a patient is diagnosed and treated appropriately, the greater the probability that he may recover from possible brain damage. However, the processes and guidelines for optimal stroke care are not maintained consistently. In Europe, less than 40 percent of the hospitals meet the minimum standards for stroke care.1
In Germany, only approximately half of the stroke patients are treated in a stroke unit, that is, a specialized stroke ward.2 And in the USA, only 4.3 percent of patients with a cerebral infarct receive timely thrombolytic treatment3 – the current stroke therapy that dissolves the blood clot (thrombus) causing reduced blood supply to the brain. With "Act on Stroke“, Siemens has developed a new consulting concept for improved stroke care management. The model integrates the analyses of processes from hospitals leading the field of stroke care worldwide and combines them with medical guidelines and current scientific results. “Act on Stroke” is backed by an interdisciplinary expert team from Siemens: physicians, strategy and workflow consultants, as well as economists, IT experts, engineers, and medical technicians.
In only five days, two of the Siemens consultants analyze the stroke processes in a hospital. Based on more than 450 individual criteria, they determine the maturity level of complex clinical processes on a scale from 1 to 5. After having evaluated the status quo and provided a detailed report, the consultants develop actions for the customer that enable workflows to be both measured and sustainably optimized with respect to time and adherence to guidelines. For example, thrombolytic therapy should be started no later than four and a half hours after onset of the first symptoms.
Siemens has yet successfully applied “Act on Stroke” to several customer sites, among them the University Clinic of Muenster, Germany, where Professor Bernd Ringelstein, MD, heads the Clinic and Polyclinic for Neurology. “Siemens analyzed the stroke processes at our hospital in a very impressive and convincing way. The recommended actions will help us to overcome residual obstacles within our processes efficiently,” says Ringelstein. Siemens aims to complete the “Act on Outcomes” program by adding other relevant areas of care, for example, the treatment of cardiac insufficiency. So far, the model has been developed for stroke and for acute coronary syndrome.
The Siemens Healthcare Sector is one of the world’s largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. Siemens offers its customers products and solutions for all aspects of patient care under one roof - from prevention and early detection and diagnosis to therapy and aftercare. By optimizing the clinical workflows designed to deal with the major disease patterns, Siemens also ensures that healthcare becomes faster, better and at the same time more cost-effective.1 Leys, D., et al: „Facilities Available in European Hospitals Treating Stroke Patients“, Stroke 2007 38; p.2985-2991
Solar Collectors from Ultra-High Performance Concrete Combine Energy Efficiency and Aesthetics
16.01.2017 | Fraunhofer-Institut für Solare Energiesysteme ISE
Energy-Efficient Building Operation: Monitoring Platform MONDAS Identifies Energy-Saving Potential
16.01.2017 | Fraunhofer-Institut für Solare Energiesysteme ISE
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences